Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere shortening has been implicated in hepatocyte senescence94 and in disease progression in patients with liver cirrhosis95.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [94]
In the citing paper
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers160.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [160]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescence-associated -Gal staining was performed as described previously (18).”
BackgroundMethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Continuous shortening of telomeres during each cell division limits the life span of primary human cells in vitro (6).”
BackgroundHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 3×
“Cirrhosis samples were grouped into samples with mild fibrosis and samples with severe fibrosis according to the Ishak criteria (19).”
MethodInfluentialStructure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · cited 1×
“The tumor suppressor p53 has been identified as a downstream target of short dysfunctional telomeres in mouse (34) and human cells (35).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo
Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., & Harley, C. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1306 · Cited by 533 · cited 2×
“It is still a matter of debate to what extent telomere shortening affects organo-pathophysiology during aging (7) or chronic diseases that induce elevated rates of cell turnover (8–11).”
BackgroundTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCurrent Protocols in Cell Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 502
Research works printed but not linked: 1
- Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000
Cited by
Items 101–200 of 547
Molecular Pathogenesis of Hepatocellular Carcinoma
Ho, D. W., Lo, R. C., Chan, L., & Ng, I. O. (2016) · Liver Cancer · doi:10.1159/000449340 · Cited by 132
Role of cellular senescence in inflammation and regeneration
Saito, Y., Yamamoto, S., & Chikenji, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00342-5 · Cited by 139
Farazi, P. A., Glickman, J., Horner, J., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis
Guerrieri, F., Belloni, L., Pediconi, N., & Levrero, M. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345721 · Cited by 118
Ningarhari, M., Caruso, S., Hirsch, T. Z., Bayard, Q., Franconi, A., Védie, A.-L., Noblet, B., Blanc, J.-F., Amaddeo, G., Ganne, N., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.052 · Cited by 116
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
“In human cirrhosis; for instance, telomere shortening is more pronounced in hepatocytes rather than in HSCs 87 .”
Sancho‐Bru, P., Najimi, M., Caruso, M., Pauwelyn, K. A., Cantz, T., Forbes, S. J., Roskams, T., Ott, M., Gehling, U. M., Sokal, E. M., et al. (2008) · Gut · doi:10.1136/gut.2008.171116 · Cited by 120
Acute-on-chronic liver failure in chronic hepatitis B: an update
Zhao, R., Shi, Y., Zhao, H., Wu, W., & Sheng, J. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1426459 · Cited by 122
Different types of liver progenitor cells and their niches
Roskams, T. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.002 · Cited by 117
“Intriguingly, mesenchymal cells like endothelial cells and hepatic stellate cells do not show this replicative senescence [16,17].”
BackgroundMuñoz-Najar, U., & Sedivy, J. M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3250 · Cited by 114
Stem cells in liver regeneration and therapy
Cantz, T., Manns, M. P., & Ott, M. (2008) · Cell and Tissue Research · doi:10.1007/s00441-007-0483-6 · Cited by 113
Self-citationXu, X., Chen, W., Miao, R., Zhou, Y., Wang, Z., Zhang, L., Wan, Y., Dong, Y., Qu, K., & Liu, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2905 · Cited by 110
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.008 · Cited by 115
“7 murine macrophage cell line (RIKEN Cell Resource Center, Tsukuba, Japan) as described previously with some modifications [28].”
BackgroundMethodPapatheodoridis, G., Sypsa, V., Dalekos, G. Ν., Yurdaydın, C., van Bömmel, F., Buti, M., Calleja, J. L., Chi, H., Goulis, J., Manolakopoulos, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.007 · Cited by 117
Obesity depresses the anti‐inflammatory HSP 70 pathway, contributing to NAFLD progression
Cangeri Di Naso, F., Rosa Porto, R., Sarubbi Fillmann, H., Maggioni, L., Vontobel Padoin, A., Jacques Ramos, R., Corá Mottin, C., Bittencourt, A., Anair Possa Marroni, N., & Ivo Homem de Bittencourt, P. (2015) · Obesity · doi:10.1002/oby.20919 · Cited by 105
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
Chauhan, R., & Lahiri, N. (2016) · Biomarkers in Cancer · doi:10.4137/bic.s34413 · Cited by 109
Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations
Schafer, M. J., Haak, A. J., Tschumperlin, D. J., & LeBrasseur, N. K. (2018) · Current Rheumatology Reports · doi:10.1007/s11926-018-0712-x · Cited by 110
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
Kato, K., Logsdon, N. J., Shin, Y.-J., Palumbo, S., Knox, A., Irish, J. D., Rounseville, S. P., Rummel, S. R., Mohamed, M., Ahmad, K., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0092oc · Cited by 113
“Numerous studies have demonstrated the accumulation of senescent cells in pathologic tissue regions of human patients with chronic fibrotic diseases, including IPF (26–29, 52), liver fibrosis (53, 54), kidney fibrosis (55), and cardiac fibrosis (56)—all of which predominantly afflict the elderly population.”
BackgroundThe evolving concept of tumor microenvironments
Laconi, E. (2007) · BioEssays · doi:10.1002/bies.20606 · Cited by 98
Pitiyage, G. N., Slijepcevic, P., Gabrani, A., Chianea, Y. G., Lim, K. P., Prime, S. S., Tilakaratne, W. M., Fortune, F., & Parkinson, E. K. (2011) · The Journal of Pathology · doi:10.1002/path.2839 · Cited by 101
Hepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Baboota, R. K., Rawshani, A., Bonnet, L., Li, X., Yang, H., Mardinoglu, A., Tchkonia, T., Kirkland, J. L., Hoffmann, A., Dietrich, A., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00620-x · Cited by 99
Predictive Factors for Hepatocellular Carcinoma in Type 1 Autoimmune Hepatitis
Montano-Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01922.x · Cited by 99
Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Self-citationSenescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
Irvine, K. M., Skoien, R., Bokil, N. J., Melino, M., Thomas, G. P., Loo, D., Gabrielli, B., Hill, M. M., Sweet, M. J., Clouston, A. D., et al. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17851 · Cited by 97
DePianto, D. J., Heiden, J. A. V., Morshead, K. B., Sun, K.-H., Modrusan, Z., Teng, G., Wolters, P. J., & Arron, J. R. (2021) · JCI Insight · doi:10.1172/jci.insight.143626 · Cited by 92
“In the liver, stellate cell senescence promotes tissue healing and regeneration while limiting fibrotic responses; however, specific telomere shortening and senescence in hepatocytes limits regenerative capacity and correlates with fibrotic progression (52, 53).”
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus
Roskams, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00333-7 · Cited by 94
The role of senescent T cells in immunopathology
Covre, L. P., De Maeyer, R. P. H., Gomes, D. C. O., & Akbar, A. N. (2020) · Aging Cell · doi:10.1111/acel.13272 · Cited by 93
“…age leads to organ dysfunction, driving inflammation and may underlie many age-related diseases such as atherosclerosis (Childs et al., 2016), osteoarthritis (Jeon et al., 2017), neurodegenerative diseases (Chinta et al., 2018; Kritsilis et al., 2018) and cirrhosis (Wiemann et al., 2002).”
BackgroundNewsholme, P., & de Bittencourt, P. I. H. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000077 · Cited by 108
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 103
Cellular senescence: Implications for metabolic disease
Schafer, M. J., Miller, J. D., & LeBrasseur, N. K. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.047 · Cited by 83
Rayhill, S. C., Wu, Y., Katz, D. A., Voigt, M. D., LaBrecque, D. R., Kirby, P., Mitros, F. A., Kalil, R. S., Miller, R. A., Stolpen, A. H., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000270313.31328.63 · Cited by 86
A Dual Role of p21 in Stem Cell Aging
Ju, Z., Choudhury, A. R., & Rudolph, K. L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.036 · Cited by 91
Self-citationSenescent endothelial cells: Potential modulators of immunosenescence and ageing
Pantsulaia, I., Ciszewski, W. M., & Niewiarowska, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.011 · Cited by 84
Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
Meijnikman, A. S., Herrema, H., Scheithauer, T. P. M., Kroon, J., Nieuwdorp, M., & Groen, A. K. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100301 · Cited by 75
“This percentage can increase to 50–100% in end-stage liver disease.(108,109) As mentioned, senescence in the liver can”
BackgroundCancer stem cells and hepatocellular carcinoma
Yao, Z., & Mishra, L. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.18.9843 · Cited by 86
Ande, S., Greenberg, R. A., Schaetzlein, S., Buer, J., Masutomi, K., Hahn, W. C., Zimmermann, S., Martens, U., Manns, M. P., & Rudolph, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5459-5474.2004 · Cited by 79
Self-citationSevere acute exacerbation of chronic hepatitis B: A unique presentation of a common disease
Wong, V. W., & Chan, H. L. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05924.x · Cited by 78
Animal models for the study of liver fibrosis: new insights from knockout mouse models
Hayashi, H., & Sakai, T. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2011 · Cited by 88
CD36 initiates the secretory phenotype during the establishment of cellular senescence
Chong, M., Yin, T., Chen, R., Xiang, H., Yuan, L., Ding, Y., Pan, C. C., Tang, Z., Alexander, P. B., Li, Q., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745274 · Cited by 81
Mirsaidi, A., Kleinhans, K. N., Rimann, M., Tiaden, A. N., Stauber, M., Rudolph, K. L., & Richards, P. J. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.440 · Cited by 77
Self-citationM2 Kupffer Cells Promote Hepatocyte Senescence
Wan, J., Benkdane, M., Alons, E., Lotersztajn, S., & Pavoine, C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.014 · Cited by 77
Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver
Verma, S., Tachtatzis, P., Penrhyn-Lowe, S., Scarpini, C., Jurk, D., Von Zglinicki, T., Coleman, N., & Alexander, G. J. M. (2012) · Hepatology · doi:10.1002/hep.25787 · Cited by 72
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Nakajima, T., Moriguchi, M., Katagishi, T., Sekoguchi, S., Nishikawa, T., Takashima, H., Kimura, H., Minami, M., Itoh, Y., Kagawa, K., et al. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01178.x · Cited by 69
Role of telomere dysfunction in aging and its detection by biomarkers
von Figura, G., Hartmann, D., Song, Z., & Rudolph, K. L. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0509-5 · Cited by 76
“Moreover, there was a significant elevation in the expression of biomarkers in blood plasma of patients with chronic diseases that are associated with increased rates of cell turnover and telomere shortening, e.g., cirrhosis and myelodysplastic syndromes [ 41 , 42].”
BackgroundSelf-citationTelomeres, NAFLD and Chronic Liver Disease
Donati, B., & Valenti, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030383 · Cited by 69
Functional Role of Cellular Senescence in Biliary Injury
Meng, L., Quezada, M., Levine, P., Han, Y., McDaniel, K., Zhou, T., Lin, E., Glaser, S., Meng, F., Francis, H., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.10.027 · Cited by 68
Senescence in tissue samples of humans with age-related diseases: A systematic review
Tuttle, C. S. L., Luesken, S. W. M., Waaijer, M. E. C., & Maier, A. B. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101334 · Cited by 64
“Liver Overall, 20/103 articles focused on diseases of the liver with liver cirrhosis (9/20)(Gutierrez-Reyes et al., 2010; Sasaki et al., 2015, 2005; Sasaki et al., 2006, 2010a; Sasaki et al., 2008, 2010b, c; Wiemann et al., 2002) the most studied pathology.”
Sekoguchi, S., Nakajima, T., Moriguchi, M., Jo, M., Nishikawa, T., Katagishi, T., Kimura, H., Minami, M., Itoh, Y., Kagawa, K., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04454.x · Cited by 67
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 70
“galactosidase and shorter telomere lengths were used to demonstrate senescence in hepatocytes from human cirrhotic liver tissue [50,51].”
BackgroundSasaki, M., Ikeda, H., Yamaguchi, J., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcpwmx47treywzg · Cited by 65
Pezzuto, F., Izzo, F., Buonaguro, L., Annunziata, C., Tatangelo, F., Botti, G., Buonaguro, F. M., & Tornesello, M. L. (2016) · Oncotarget · doi:10.18632/oncotarget.9801 · Cited by 70
Telomeres and Telomerase in the Development of Liver Cancer
der Stroth, L. I., Tharehalli, U., Güneş, Ç., & Lechel, A. (2020) · Cancers · doi:10.3390/cancers12082048 · Cited by 77
“However, telomere shortening occurs in the absence of sufficient telomerase activity in hepatocytes under conditions of chronic liver diseases or upon injury [21,25].”
BackgroundA regulatory SNP of the BICD1 gene contributes to telomere length variation in humans
Mangino, M., Brouilette, S., Braund, P., Tirmizi, N., Vasa-Nicotera, M., Thompson, J. R., & Samani, N. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn152 · Cited by 66
Zhang, F., Lu, Y., & Zheng, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.008 · Cited by 73
Siegl-Cachedenier, I., Flores, I., Klatt, P., & Blasco, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704141 · Cited by 64
“, 2007; for review see Blasco, 2005) and are also associated with different disease states (Samani et al., 2001; Wiemann et al., 2002; Cawthon et al., 2003; Epel et al., 2004; Valdes et al., 2005).”
Self-citationExtended Criteria Donors in Liver Transplantation: Adapting Donor Quality and Recipient
Gastaca, M. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.02.016 · Cited by 63
Sperka, T., Song, Z., Morita, Y., Nalapareddy, K., Guachalla, L. M., Lechel, A., Begus‐Nahrmann, Y., Burkhalter, M. D., Mach, M., Schlaudraff, F., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2388 · Cited by 68
Self-citationGuo, H., Liu, Z., Xu, B., Hu, H., Wei, Z., Liu, Q., Zhang, X., Ding, X., Wang, Y., Zhao, M., et al. (2013) · Aging Cell · doi:10.1111/acel.12138 · Cited by 62
New insights into liver regeneration
Gilgenkrantz, H., & de l’Hortet, A. C. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.04.002 · Cited by 63
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 68
Telomere dynamics: the influence of folate and DNA methylation
Moores, C. J., Fenech, M. F., & O’Callaghan, N. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06101.x · Cited by 65
Relationships Among Stellate Cell Activation, Progenitor Cells, and Hepatic Regeneration
Roskams, T. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.014 · Cited by 64
Yildiz, G., Arslan-Ergul, A., Bagislar, S., Konu, O., Yuzugullu, H., Gursoy-Yuzugullu, O., Ozturk, N., Ozen, C., Ozdag, H., Erdal, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064016 · Cited by 62
Anesthetic Isoflurane Induces DNA Damage Through Oxidative Stress and p53 Pathway
Ni, C., Li, C., Dong, Y., Guo, X., Zhang, Y., & Xie, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9937-8 · Cited by 61
New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article
Ebrahimi, H., Naderian, M., & Sohrabpour, A. A. (2016) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2016.29 · Cited by 70
Cellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Tümpel, S., & Rudolph, K. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06547.x · Cited by 54
Self-citationNakajima, T., Nakashima, T., Okada, Y., Jo, M., Nishikawa, T., Mitsumoto, Y., Katagishi, T., Kimura, H., Itoh, Y., Kagawa, K., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2009.02504.x · Cited by 56
Tachtatzis, P. M., Marshall, A., Aravinthan, A., Verma, S., Penrhyn-Lowe, S., Mela, M., Scarpini, C., Davies, S. E., Coleman, N., & Alexander, G. J. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127511 · Cited by 58
Telomere and telomerase in chronic liver disease and hepatocarcinoma
Carulli, L., & Anzivino, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6287 · Cited by 57
The relationship between telomere length and aging-related diseases
Huang, X., Huang, L., Lu, J., Cheng, L., Wu, D. A., Li, L., Zhang, S., Lai, X., & Xu, L. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01608-z · Cited by 63
Hepatocellular Carcinoma and Other Malignancies in Autoimmune Hepatitis
Czaja, A. J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2525-5 · Cited by 57
Sasaki, M., Ikeda, H., & Nakanuma, Y. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.03.005 · Cited by 57
Fu, X., Wan, S., Hann, H., Myers, R. E., Hann, R. S., Au, J. S., Chen, B., Xing, J., & Yang, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.066 · Cited by 55
Donati, B., Pietrelli, A., Pingitore, P., Dongiovanni, P., Caddeo, A., Walker, L., Baselli, G., Pelusi, S., Rosso, C., Vanni, E., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1078 · Cited by 52
Old cells, new tricks: chromatin structure in senescence
Parry, A. J., & Narita, M. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9628-9 · Cited by 53
Hoare, M., Gelson, W. T. H., Das, A., Fletcher, J. M., Davies, S. E., Curran, M. D., Vowler, S. L., Maini, M. K., Akbar, A. N., & Alexander, G. J. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.005 · Cited by 53
Gungor, M. Z., Uysal, M., & Şentürk, Ş. (2022) · Cancers · doi:10.3390/cancers14040940 · Cited by 58
“Another dimension of complexity in this context is the causal relationship between replicative senescence and hepatocyte-specific telomere shortening [97].”
BackgroundPawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 70
“…et al., 2004; Sedelnikova et al., 2004; Wang et al., 2009), and, moreover, the accumulation of senescent cells is also related to ageassociated tissue pathologies, such as osteoarthritis, atherosclerosis and liver cirrhosis (Minamino and Komuro, 2007; Price et al., 2002; Wiemann et al., 2002).”
BackgroundAmir, M., Κhan, P., Queen, A., Dohare, R., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020) · Cells · doi:10.3390/cells9020359 · Cited by 57
Sato, R., Maesawa, C., Fujisawa, K., Wada, K., Oikawa, K., Takikawa, Y., Suzuki, K., Oikawa, H., Ishikawa, K., & Masuda, T. (2004) · Gut · doi:10.1136/gut.2003.027516 · Cited by 52
Zhang, X., Strakovsky, R. S., Zhou, D., Zhang, Y., & Pan, Y. (2011) · Journal of Nutrition · doi:10.3945/jn.111.139576 · Cited by 54
“Hepatocellular telomere shortening and senescence are considered as markers of liver cirrosis (Wiemann et al., 2002).”
BackgroundTelomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis
Laish, I., Mannasse-Green, B., Hadary, R., Biron-Shental, T., Konikoff, F. M., Amiel, A., & Kitay-Cohen, Y. (2016) · Cytogenetic and Genome Research · doi:10.1159/000454654 · Cited by 49
Nalapareddy, K., Jiang, H., Gutierrez, L. M. G., & Rudolph, K. L. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.09.002 · Cited by 50
Self-citationBiomarkers of ageing of humans and non-human primates
Wu, Z., Qu, J. T., Zhang, W., Bao, Z., Bi, Y., Cai, J.-P., Cai, S.-Q., Cao, C.-M., Cao, F., Cao, Z., et al. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00883-8 · Cited by 59
“An increase in DNA methylation age (discussed subsequently) and transcriptional noise can also be indicative of liver ageing 14,31,265–268 , and increased expression of metabolic enzymes such as ACSL4, SCAD, CYP1A2 and PCSK9, and of SREBP2, may serve as potential indicators of liver ageing in…”
The Zebrafish as an Emerging Model to Study DNA Damage in Aging, Cancer and Other Diseases
Cayuela, M. L., Claes, K., Ferreira, M. G., Henriques, C. M., Eeden, F. V., Varga, M., Vierstraete, J., & Mione, M. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00178 · Cited by 52
“, 2002), liver cirrhosis (Wiemann et al., 2002), chronic obstructive pulmonary disease (Amsellem et al.”
BackgroundAnatomic Pathology of Hepatocellular Carcinoma: Impact on Prognosis and Response to Therapy
Roskams, T. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.004 · Cited by 56
Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
Pezzuto, F., Buonaguro, L., Buonaguro, F. M., & Tornesello, M. L. (2017) · Infectious Agents and Cancer · doi:10.1186/s13027-017-0138-5 · Cited by 48
Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection
Wandrer, F., Han, B., Liebig, S., Schlue, J., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14802 · Cited by 49
“In contrast, in human liver cirrhosis HSC senescence was not observed.(25) While the effects of senescence for resolution vs progression of fibrosis might depend on the type of liver injury, also various cell types have identified to undergo senescence.”
BackgroundSelf-citationSenescence and the Pro-tumorigenic Stroma
Alspach, E., Fu, Y., & Stewart, S. A. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2014010630 · Cited by 47
Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
Baiocchi, L., Glaser, S. S., Francis, H., Kennedy, L. L., Felli, É., Alpini, G. D., & Gracia‐Sancho, J. (2021) · Hepatology Communications · doi:10.1002/hep4.1725 · Cited by 50
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems
Serene, R. L. (2005) · Frontiers in bioscience · doi:10.2741/1661 · Cited by 50
Hepatoprotective Effects of Swimming Exercise against D-Galactose-Induced Senescence Rat Model
Huang, C.-C., Chiang, W.-D., Huang, W.-C., Huang, C.-Y., Hsu, M.-C., & Lin, W.-T. (2013) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2013/275431 · Cited by 44
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Zheng, L., He, S., Wang, H., Li, J., Liu, Y., & Liu, S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0206 · Cited by 81
Hepatic manifestations of telomere biology disorders
Patnaik, M. M., Kamath, P. S., & Simonetto, D. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.006 · Cited by 46
Xiang, X.-H., Yang, L., Zhang, X., Ma, X.-H., Miao, R.-C., Gu, J.-X., Fu, Y.-N., Yao, Q., Zhang, J.-Y., Liu, C., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i14.1715 · Cited by 44
Metadata
- Authors
- WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
- Consejo Superior de Investigaciones Científicas (ES)
- Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 9
- Pages
- 935-942
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166704790
- Cited by
- 527
- References
- 34
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
- Deutsche Krebshilfe (10-1809-Ru1)
- Ministerio de Ciencia y Tecnología
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.